Adenoid cystic carcinoma of the lacrimal gland: role of nuclear survivin (BIRC5) as a prognostic marker

Aims This study aimed to evaluate the expression of nuclear survivin in adenoid cystic carcinoma (ACC) of the lacrimal gland and to determine if this expression is associated with histopathological features, markers of apoptosis and proliferation or clinical outcomes. Methods and results Immunohisto...

Full description

Saved in:
Bibliographic Details
Published inHistopathology Vol. 62; no. 6; pp. 840 - 846
Main Authors Mulay, Kaustubh, Puthyapurayil, Fairooz M, Mohammad, Javed Ali, Hasnat Ali, Mohammad, Honavar, Santosh G, Reddy, Vijay Anand P
Format Journal Article
LanguageEnglish
Published England Blackwell Publishing Ltd 01.05.2013
Wiley Subscription Services, Inc
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Aims This study aimed to evaluate the expression of nuclear survivin in adenoid cystic carcinoma (ACC) of the lacrimal gland and to determine if this expression is associated with histopathological features, markers of apoptosis and proliferation or clinical outcomes. Methods and results Immunohistochemical staining for survivin, p53, Ki‐67 and Bcl‐2 was analyzed in 55 cases of ACC of lacrimal gland. Thirty‐one cases (56.3%) expressed nuclear survivin. All cases expressed p53, Ki‐67 and Bcl‐2. Eleven cases (35.5%) had a high nuclear survivin score (NS‐SCORE) and 20 cases (64.5%) had a low NS‐SCORE. Cases with a high NS‐SCORE had a shorter progression‐free survival (PFS) (P < 0.0001), higher expression of Ki‐67 (P < 0.005) and a solid tumour pattern >30% (P < 0.005). Conclusion Nuclear expression of survivin impacts prognosis significantly and is thus a promising prognostic marker in ACC of the lacrimal gland.
Bibliography:ArticleID:HIS12073
istex:79527B2DD2773BDAC2E5DC5B424A6F834D325B95
ark:/67375/WNG-CGRTS3VQ-G
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0309-0167
1365-2559
DOI:10.1111/his.12073